FEATURES OF THE CLINICAL SIGNIFICANCE OF POLYMORPHIC VARIANTS OF ENOS AND AGTR2 GENES IN PATIENTS WITH CAD

Coronary heart disease (CHD) is a major cause of mortality. Morphological substrate of CHD in most cases is atherosclerosis, which is based on structural genes polymorphism eNOS and AGTR2. The aim of the study was to study the prevalence of eNOS and AGTR2 genes in patients with coronary artery disease and the association of these genes with coronary heart disease. The study involved 187 patients aged 36 to 86 years (62,2±11,2) with different forms of CHD: stable and unstable angina, myocardial infarction and 45 people without CHD. Determination of gene polymorphisms was performed by real-time PCR analyzer of nucleic acids IQ 5 Bio-Rad. Statistical analysis was performed using Statistica 10.0. The study revealed a significant difference between the incidence of homozygous AA allelic variant gene AGTR2 group of patients with myocardial infarction and the comparison group; polymorphic variant AA AGTR2 gene is associated with earlier onset of coronary artery disease; It found that carriers of the polymorphic variant gene GA AGTR2 beginning statistically CHD occurred significantly later than in carriers of alleles GG and AA; age CHD debut TT allele carriers of the eNOS gene is associated with an earlier onset of the disease and statistically significantly different from the age of first CHD in carriers of alleles of polymorphic variants of GG and GT; revealed a positive correlation between the polymorphic allele AGTR2 gene with the presence of arterial hypertension in patients with coronary artery disease; It determined that the T allele carriers of the polymorphic gene eNOS is associated more early onset of hypertension, found the association of the polymorphic allele gene AGTR2 the need to use higher doses of ACE inhibitor — perindopril.

coronary heart disease, gene polymorphism, eNOS, AGTR2

1. Akimceva E.A., Kotovshhikova E.F. Markers of endothelial dysfunction as predictors of coronary stents rethrombosis. Medicinskie nauki [Medical sciences]. 2012; 8: 271-273. (In Russian).

2. Zatejshhikov D.A., Manushkina L.O., Kudrjashova O.Ju et al.. Polymorphism of NO- synthase gene and angiotensin II type 1 and endothelial hemostasis in patients with coronary heart disease. Kardiologija [Cardiology]. 2000; 11(40): 28-32. (In Russian).

3. Lutaj M.I. Atherosclerosis: a modern view of the pathogenesis. Ukrainskij kardіologicheskij zhurnal [Ukrainian Journal of Cardiology]. 2004; 1: 22-34. (In Russian).

4. Mihin V.P., Djumina N.V., Koltunova T.Ju., Sharova V.G., Zueva O.N. Dysfunction of the vascular endothelium and methods of its correction cytoprotector. Poliklinika [Policlinic]. 2008; 5: 52-55. (In Russian).

5. Perepech N.B. Angiotensin II receptor antagonists in search of " pharmacological niche". Consilium Medicum [Consilium Medicum]. 2007; 5(9): 36-44. (In Russian).

6. Reshetnikov E.A., Akulova L.Ju., Batluckaja I.V. Molecular genetic mechanisms of the functioning of the cardiovascular system and the role of the renin-angiotensin system in the maintenance of cardiovascular reactions in the body. Nauchnye vedomosti [Scientific sheets]. 2013; 11: 179-183. (In Russian).

7. Rybachkova J.V. Pharmacoepidemiological and genetic aspects of chronic heart failure with hypertension. Avtoreferat [Synopsis]. 2013. (In Russian).

8. Sychev D.A., Kukes V.G. Domestic experience of pharmacogenetic testing for warfarin dosing personalization : a real opportunity for the Russian doctor. Consilium medicum [Consilium Medicum]. 2013; 10: 111-115. (In Russian).

9. Shunikova M.I., Khokhlov A.L., Sosnin A.J. Reversibility of remodeling of heart and vessels in elderly patients on the background of antihypertensive therapy. Clinical gerontology. 2008; 3(14): 17-21. (In Russian).

10. Shunikova M.I., Khokhlov A.L., Sosnin A.J. Comparative evaluation of protective properties of fosinopril, amlodipine and metoprolol in patients with arterial hypertension. Consilium Medicum. 2008; 11(10): 30-35. (In Russian).

11. Casas J.P., Bautista L.E., Humphries S.E., Hingorani A.D. Endothelial nitric oxide synthase genotype and ischemic disease. Meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004; 109: 1359-1365.

12. Colombo M. G., Andreassi M.G. et al. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart. 2002; 87(6): 525–528.

13. Hayet Soualmia. Candidate Genes in Hypertension, Genetics and Pathophysiology of Essential Hypertension. Genetics and Pathophysiology of Essential Hypertension Edited by Prof. Madhu Khullar. 2012: 139-168.

14. Hingorani A.D., Liang C.F., Fatibene J., et al. A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999; 100(14): 1515-1520.

15. Jin J.J., Nakura J., Wu z. association of angiotensin II type 2 receptor gene variant with hypertension. Hypertens. Res. 2003; 7(Pt26): 547-552.

16. Jones A. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension. Hypertension. 2003; 42(4): 500-506.

17. Gendron L., Payet M.D., Gallo-Payet N. The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms. Journal of Molecular Endocrinology. 2003; 31: 359-372.

18. Li J., Cun Y., Tang W. R. et al. Association of eNOS gene polymorphisms with essential hypertension in the Han population in southwestern China. Genet. Mol. Res. 2011; 10(3): 2202-2212.

19. Zhou M.S., Schulman I.H., Raij L. Nitric Oxide, Angiotensin II, and Hypertension. Seminars in Nephrology. 2004; 4 (Pt24): 366-378.

20. Markus H.S., Ruigrok Y., Ali N., Powell J.F. Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke. 1998; 29(9): 1908-1911.

21. Naber C.K., Oldenburg O., Frey U. et al. Relevance of the T-786C and Glu298Asp variants in the endothelial nitric oxide synthase gene for cholinergic and adrenergic coronary vasomotor responses in man. Circulation. 2003; 106: 1042.

22. Shimasaki Y., Yasue H., Yoshimura M., et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J. Am. Coll. Cardiol. 1998; 31(7): 1506-1510.